Invention Grant
- Patent Title: Crystalline form of gemcitabine
-
Application No.: US16065369Application Date: 2016-12-21
-
Publication No.: US11377467B2Publication Date: 2022-07-05
- Inventor: Hugh Griffith
- Applicant: NuCana plc
- Applicant Address: GB Edinburgh
- Assignee: NuCana plc
- Current Assignee: NuCana plc
- Current Assignee Address: GB Edinburgh
- Agency: Knowles Intellectual Property Strategies, LLC
- Priority: GB1522771 20151223
- International Application: PCT/GB2016/054017 WO 20161221
- International Announcement: WO2017/109485 WO 20170629
- Main IPC: C07H19/06
- IPC: C07H19/06
Abstract:
This invention relates to a crystalline form of gemcitabine-[phenyl-(benzoxy-L-alaninyl)]-(S)-phosphate.
Public/Granted literature
- US20210188893A1 CRYSTALLINE FORM OF GEMCITABINE Public/Granted day:2021-06-24
Information query
IPC分类:
